Founded in 2010 and is headquartered in Cambridge, Massachusetts, the company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. A biotechnology company, Moderna develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases.
One of the COVID-19 Headline Stocks, MRNA Stock Options have weekly expirations and trade in increments of $2.50.
2021 Range: (103.26 – 497.49)
2020 Close: 102.66
Get this week and next week’s MRNA Options Trade Forecast view by clicking here
Weekly Chart
Daily Chart
5 Day Chart
Get the MRNA Monthly and LEAP Options Trade Forecast view by clicking here
Pivot Points
(updated weekly after Friday’s close)
Support/Resistance Levels | Price | Key Turning Points |
---|---|---|
14 Day RSI at 80% | 579.35 | |
52-Week High | 497.49 | |
13-Week High | 453.61 | |
14 Day RSI at 70% | 413.68 | |
1-Month High | 376.65 | |
360.92 | 38.2% Retracement From 13 Week High | |
346.66 | 38.2% Retracement From 52 Week High | |
332.29 | 50% Retracement From 13 Week High/Low | |
321.97 | 38.2% Retracement From 4 Week High | |
305.08 | 50% Retracement From 4 Week High/Low | |
303.65 | 38.2% Retracement From 13 Week Low | |
300.08 | 50% Retracement From 52 Week High/Low | |
288.19 | 38.2% Retracement From 4 Week Low | |
281.15 | 14 Day RSI at 50% | |
253.49 | 38.2% Retracement From 52 Week Low | |
Last | 249.99 | Last |
1-Month Low | 233.51 | |
13-Week Low | 210.96 | |
14 Day RSI at 30% | 190.16 | |
52-Week Low | 102.66 | |
14 Day RSI at 20% | 76.43 |